Our mission is to solve important clinical problems by applying first principles from chemistry and engineering.
We believe that Seeing is Curing - that is, if we can see cancer at an earlier stage than we now can (currently about 1 billion cells) we will have a greater likelihood of curing it.
A. LAM tumor in the lung with hematoxylin and
eosin (H&E) staining
B. PET/CT using F-18-FDG
C. Thyroid uptake of pertechnetate by SPECT/CT
D. Prostate cancer with H&E staining
5/4/2012
Postdoctoral Researcher Vivek Venugopal, Ph.D. wins the Karen and Lester Gerhardt Prize in Science and Engineering and the Zelda and David G. Gisser Prize in Biomedical Engineering from Rensselaer Polytechnic Institute for his doctoral dissertation.
4/6/2012
Drs. Frangioni and Weissleder create Harvard's first continuing
medical education (CME) course on molecular imaging. Molecular Imaging:
Preclinical and Clinical Advances will be held October 16 to 19, 2012 at the
beautiful Fairmont Copley Plaza in Boston, MA. Download the course brochure for more information.
2/9/2012
Yoshitomo Ashitate, M.D. is appointed Senior Surgeon at the Center for
Molecular Imaging in recognition of his 6 first author papers on innovative
technology for image-guided surgery.
2/2/2012
Research Assistant Yang (Allison) Xie is accepted to 2 different top-rated medical schools.
11/1/2011
Dr. Frangioni awarded second Professorship at Harvard Medical School. He is now Professor of Medicine and Professor of Radiology.